Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Inbal Mazal
Correction: Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors With Three Different Drug Combinations
PLoS ONE
Multidisciplinary
Related publications
PARP-1 Regulates Resistance of Pancreatic Cancer to TRAIL Therapy
Clinical Cancer Research
Cancer Research
Oncology
PARP Inhibitors in Ovarian Cancer: Sensitivity Prediction and Resistance Mechanisms
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Treating Cancer With Phosphatidylinositol-3-Kinase Inhibitors: Increasing Efficacy and Overcoming Resistance
Journal of Lipid Research
Biochemistry
Endocrinology
Cell Biology
PARP Inhibitors in Ovarian Cancer
Personalized Drug Combinations to Overcome Trastuzumab Resistance in HER2-positive Breast Cancer
Biochimica et Biophysica Acta - Reviews on Cancer
Cancer Research
Oncology
Genetics
Barrier to Resistance of Dolutegravir in Two-Drug Combinations
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
The Inhibition and Treatment of Breast Cancer With Poly (ADP-ribose) Polymerase (PARP-1) Inhibitors
International Journal of Biological Sciences
Applied Microbiology
Evolution
Ecology
Developmental Biology
Cell Biology
Molecular Biology
Systematics
Behavior
Biotechnology
Layer‐by‐Layer Nanoparticles for Novel Delivery of Cisplatin and PARP Inhibitors for Platinum‐Based Drug Resistance Therapy in Ovarian Cancer
Bioengineering & Translational Medicine
Overcoming Resistance to HER2 Inhibitors Through State-Specific Kinase Binding
Nature Chemical Biology
Cell Biology
Molecular Biology